Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06339450
Other study ID # ExpoCF
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date May 1, 2024
Est. completion date December 31, 2027

Study information

Verified date March 2024
Source Centre Hospitalier Intercommunal Creteil
Contact camille Jung
Phone 0157022268
Email camille.jung@chicreteil.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Cystic fibrosis (CF) is the most common autosomal recessive disease that leads to early mortality in Caucasians and affects around 7500 patients in France. Progression of the disease depends on pulmonary exacerbations defined as acute deterioration of respiratory symptoms which ultimately impair lung function and quality of life. Most frequently caused by lung bacterial infections, exacerbations' effects include increased cough, increased sputum production, increased use of antibiotics, dyspnea and decreased lung function. The phenotypic variability of CF suggests the implication of other contributors especially to the CF airway disease. Beside genetic and epigenetic alterations, environmental factors - e.g tobacco smoke, air pollution, temperature changes, food intake - appear as relevant candidates. A previous review has discussed current knowledge on the effects of air pollution on the course of CF disease. Although scarce, the existing epidemiological andexperimental literature suggests a link between exposure to air pollutants and adverse health effects.Although scarce, the existing epidemiological and experimental literature suggests a link between exposure to air pollutants and adverse health effects. The EU sponsored REMEDIA project (Impact of exposome on the course of lung diseases, Grant agreement ID 874753) contributes to the understanding of the influence of the exposome on chronic obstructive pulmonary disease (COPD) and CF. Objective of work package 3 within the REMEDIA project is the development of a mobile environmental sensor toolbox that is capable to assess the external exposome. The biomarkertoolbox was developed and tested in a proof-of-concept study carried out in healthy volunteers. The next step is to validate the collectionof exhaled breath condensate (EBC) in a real-life study. In this aim, the objective of the present study will be to assess the feasibility of EBC collection in CF patients and healthy individuals


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 16
Est. completion date December 31, 2027
Est. primary completion date July 1, 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Normal blood test - Negative Cotinine test - Protocole (RiPH2) - Normal ECG - Normal alcohol test - Lung function with FEV1 predicted = 40% at spirometry. Exclusion Criteria: - None

Study Design


Intervention

Other:
walk tours
During 5 days the patient will walk 4 hours in urban green space (open-space areas reserved for parks and other "green spaces", including plant life, water features -also referred to as blue spaces and other kinds of natural environment). The 3 hours walk tour includes a lunch break of one hour in the green space. During 5 days the patient will walk 4 hours in urban space (including 3 hours walk around the city and one-hour lunch break.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Intercommunal Creteil

Outcome

Type Measure Description Time frame Safety issue
Primary Collection of exhaled breath condensate (EBC) for biomarker analysis Levels of 3-Nitrotyrosin, Hexanal, Neutrophil Elastase in EBC day 1
Primary Collection of exhaled breath condensate (EBC) for biomarker analysis Levels of 3-Nitrotyrosin, Hexanal, Neutrophil Elastase in EBC days 3
Primary Collection of exhaled breath condensate (EBC) for biomarker analysis Levels of 3-Nitrotyrosin, Hexanal, Neutrophil Elastase in EBC days 5
Primary Collection of exhaled breath condensate (EBC) for biomarker analysis Levels of 3-Nitrotyrosin, Hexanal, Neutrophil Elastase in EBC days 6
Primary Collection of exhaled breath condensate (EBC) for biomarker analysis Levels of 3-Nitrotyrosin, Hexanal, Neutrophil Elastase in EBC days 8
Primary Collection of exhaled breath condensate (EBC) for biomarker analysis Levels of 3-Nitrotyrosin, Hexanal, Neutrophil Elastase in EBC days 10
Secondary Dysfunction or misused, failure, of EBC and sensor device rate of Dysfunction or misused, failure, of EBC and sensor device days 10
Secondary Show correlation of biomarker signal with environmental sensor system in a clinical challenge setting in healthy and CF patients. Correlation of environmental exposome signal biomark days 5
Secondary Describe differences in CF subjects vs. healthy controls Comparison of environmental exposome signal biomarker and environmental sensor measures in healthy individuals and CF patients days 5
Secondary Impact of environment exposome on health status and lung function Lung function testing and health questionnaire score before and after working trial in urban and green zone days 5
Secondary Show correlation of biomarker signal with environmental sensor system in a clinical challenge setting in healthy and CF patients. Correlation of environmental exposome signal biomark days 10
Secondary Describe differences in CF subjects vs. healthy controls Comparison of environmental exposome signal biomarker and environmental sensor measures in healthy individuals and CF patients days 10
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05541653 - The IGNITE Study on Concentrated Investment in Black Neighborhoods N/A
Completed NCT04028791 - Sickle Cell Trait and Exercise, Effect of Hot Environment N/A
Not yet recruiting NCT05105386 - The Impact of Synergies of Indoor Air Pollutants on Childhood Health and Wellbeing
Completed NCT05507944 - FeNO Hairdressers Pilot
Completed NCT04146025 - Nurtured in Nature N/A
Recruiting NCT05179993 - Detection of Microplastics in Human Granulosa Cells and in the Follicular Fluid of Women Undergoing ICSI Treatment
Completed NCT03444922 - Effects of BPA on Insulin and Glucose Responses N/A
Recruiting NCT03319927 - Reducing Pesticide Exposures in Child Care Centers N/A
Recruiting NCT05500690 - Understanding Effects of Folic Acid on the Methylosome and Transcriptome of Women With Spina Bifida Affected Pregnancies N/A
Recruiting NCT05394363 - Generation Victoria Cohort 2020s: A Statewide Longitudinal Cohort Study of Victorian Children and Their Parents
Completed NCT00021658 - Effects of Pesticide Exposure on Neurodevelopment/Growth/Respiratory Health N/A
Not yet recruiting NCT05315388 - Effects of "Vitamin N" Nature Immersion Therapy on Stress Levels in Health Care Workers in the City of Bogotá N/A
Recruiting NCT06107933 - Developmental Impacts of Microplastics Exposure in Early Life
Completed NCT03631667 - Ultralow Dose PAH Binary Mixture Study Early Phase 1
Completed NCT02540408 - Detection and Characterization of COPD in Dairy Farmers N/A
Completed NCT03440307 - Intervention to Reduce Bisphenol A Exposure in Women N/A
Completed NCT05160948 - Change in Knowledge After Receiving Personal Air Pollution Results
Recruiting NCT05865782 - Reconstructing Schoolyards With Greenery to Increase Schoolchildren's Physical Activity and Mitigate Climate Changes N/A
Completed NCT02707172 - Removal of Dermal Exposure to Phthalate Ester by Hand Washing N/A
Active, not recruiting NCT03215368 - The Ma'Anshan Birth Cohort (MABC)